This article is authored by Dr Kirti Chadha, chief scientific and innovation officer, Metropolis Healthcare Limited.

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment. Heather Quintana Suchan, a ...

Findings published in the American Journal of Human Genetics reveals widespread use of rapid genome sequencing (rGS) demonstrates that more critically ill infants should be tested to reduce missed ...

This research highlights the scale and clinical impact of GeneDx Infinity™ - the largest and most comprehensive rare disease genomic dataset - and GeneDx's leadership in bringing exome and genome ...

Northwestern Medicine and Tempus AI, Inc. (NASDAQ: TEM) are collaborating to expand access to genomic testing for Northwestern Medicine cancer patients. The goal is to provide nearly every patient ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative (GTC) today announced it received UKCA marks for its Hematology Profile Plus, Solid Tumor Plus as well as its Liquid Trace Hematology ...

Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...

Pulmonology and genetics experts from two Utah healthcare organizations have collaboratively developed a new diagnostic genomic testing method for a rare form of pulmonary hypertension caused by a ...

Tens of thousands of patients with lung cancer in the United Kingdom are missing out on targeted treatment that could improve their prognosis due to delays in genomic testing, a new report has warned.

Genomic Testing Cooperative Receives UKCA Mark for its Portfolio of Hematology, Solid Tumors and Liquid Biopsy Profiles covering DNA and RNA Genomic Testing Cooperative (GTC) today announced it ...